Safety Study of PI-0824 to Treat Pemphigus Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

March 31, 2005

Conditions
Pemphigus Vulgaris
Interventions
DRUG

PI-0824

Trial Locations (8)

10016

NYU School of Medicine, New York

11040

Long Island Jewish Medical Center, New Hyde Park

11733

Stony Brook Dermatology Associates, East Setauket

19104

University of Pennsylvania, Philadelphia

21205

Johns Hopkins School of Medicine, Baltimore

44106

Case Western Reserve University, Cleveland

94107

University of California San Francisco, San Francisco

01952

East Coast Clinical Research, Salisbury

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Peptimmune

INDUSTRY